Ruyi Lin

748 total citations
15 papers, 565 citations indexed

About

Ruyi Lin is a scholar working on Molecular Biology, Biomedical Engineering and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ruyi Lin has authored 15 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Biomedical Engineering and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ruyi Lin's work include Nanoplatforms for cancer theranostics (4 papers), Extracellular vesicles in disease (3 papers) and Mesenchymal stem cell research (3 papers). Ruyi Lin is often cited by papers focused on Nanoplatforms for cancer theranostics (4 papers), Extracellular vesicles in disease (3 papers) and Mesenchymal stem cell research (3 papers). Ruyi Lin collaborates with scholars based in China, Russia and Japan. Ruyi Lin's co-authors include Huile Gao, Jianqing Gao, Wenqi Yu, Xianchun Chen, Xinchi Jiang, Honghui Wu, Tianyuan Zhang, Ting Huang, Huilin Zhang and Ni Li and has published in prestigious journals such as Nature Communications, Advanced Functional Materials and Advanced Drug Delivery Reviews.

In The Last Decade

Ruyi Lin

15 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ruyi Lin China	12	271	232	98	88	86	15	565
Hyun-Ki Min South Korea	10	239 0.9×	203 0.9×	138 1.4×	102 1.2×	54 0.6×	12	489
Zefang Lu China	8	313 1.2×	229 1.0×	26 0.3×	204 2.3×	86 1.0×	13	635
Bozhao Li China	11	337 1.2×	271 1.2×	26 0.3×	216 2.5×	105 1.2×	20	719
Qixuan Dai China	14	519 1.9×	148 0.6×	146 1.5×	92 1.0×	36 0.4×	24	715
Shaohui Deng China	13	265 1.0×	280 1.2×	13 0.1×	80 0.9×	54 0.6×	41	653
Chenchen Mao China	16	290 1.1×	870 3.8×	20 0.2×	77 0.9×	53 0.6×	34	1.2k
Tetiana Korzun United States	12	241 0.9×	248 1.1×	15 0.2×	185 2.1×	120 1.4×	27	702
Fei Hou China	12	237 0.9×	151 0.7×	15 0.2×	197 2.2×	141 1.6×	18	615
Shunli Fu China	14	334 1.2×	182 0.8×	14 0.1×	144 1.6×	236 2.7×	31	563
Baharak Bahmani United States	13	350 1.3×	222 1.0×	16 0.2×	168 1.9×	192 2.2×	21	688

Countries citing papers authored by Ruyi Lin

Since Specialization

Citations

This map shows the geographic impact of Ruyi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruyi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruyi Lin more than expected).

Fields of papers citing papers by Ruyi Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruyi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruyi Lin. The network helps show where Ruyi Lin may publish in the future.

Co-authorship network of co-authors of Ruyi Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Ruyi Lin. A scholar is included among the top collaborators of Ruyi Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruyi Lin. Ruyi Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Lin, Ruyi, et al.. (2024). A large‐scale production of mesenchymal stem cells and their exosomes for an efficient treatment against lung inflammation. Biotechnology Journal. 19(2). e2300174–e2300174. 11 indexed citations

Lin, Ruyi, Fan Tong, Xue Xia, et al.. (2024). Self‐Delivered Transformable Nanosystem Capable of Enhancing Photodynamic Effectiveness and Multi‐Target Ameliorating Immunosuppression for Treatment of Breast Cancer and Lung Metastasis. Advanced Functional Materials. 34(42). 16 indexed citations

Zheng, Xixi, Ruyi Lin, Hao Sun, et al.. (2024). Lyophilizable Stem Cell‐Hybrid Liposome with Long‐Term Stability and High Targeting Capacity. Advanced Healthcare Materials. 13(22). e2400704–e2400704. 4 indexed citations

Zhang, Weiwei, Lei Lei, Fan Tong, et al.. (2023). Combination losartan with hyaluronic acid modified diethyldithiocarbamate loaded hollow copper sulfide nanoparticles for the treatment of breast cancer and metastasis. Chinese Chemical Letters. 35(3). 108765–108765. 28 indexed citations

Huang, Ting, Hao Sun, Ruyi Lin, et al.. (2023). High Targeting Specificity toward Pulmonary Inflammation Using Mesenchymal Stem Cell‐Hybrid Nanovehicle for an Efficient Inflammation Intervention. Advanced Healthcare Materials. 12(23). e2300376–e2300376. 11 indexed citations

Huang, Ting, Ruyi Lin, Xiaoyan Lu, et al.. (2023). Efficient intervention for pulmonary fibrosis via mitochondrial transfer promoted by mitochondrial biogenesis. Nature Communications. 14(1). 5781–5781. 61 indexed citations

Lin, Ruyi, Tianyuan Zhang, & Jianqing Gao. (2023). Apoptotic Vesicles of MSCs: The Natural Therapeutic Agents and Bio‐Vehicles for Targeting Drug Delivery. Small. 19(47). e2301671–e2301671. 28 indexed citations

Zhang, Huilin, Yiwei Zhang, Wenqin Yang, et al.. (2023). In Situ Tumor Vaccine for Lymph Nodes Delivery and Cancer Therapy Based on Small Size Nanoadjuvant. Small. 19(33). e2301041–e2301041. 39 indexed citations

Zhang, Tianyuan, Ruyi Lin, Honghui Wu, Xinchi Jiang, & Jianqing Gao. (2022). Mesenchymal stem cells: A living carrier for active tumor-targeted delivery. Advanced Drug Delivery Reviews. 185. 114300–114300. 51 indexed citations

10.

Huang, Ting, Xinchi Jiang, Qiong Bian, et al.. (2021). Iron oxide nanoparticles augment the intercellular mitochondrial transfer–mediated therapy. Science Advances. 7(40). eabj0534–eabj0534. 100 indexed citations

11.

Zhang, Tianyuan, Ting Huang, Ruyi Lin, et al.. (2021). Iron Oxide Nanoparticles Promote Cx43-Overexpression of Mesenchymal Stem Cells for Efficient Suicide Gene Therapy during Glioma Treatment. Theranostics. 11(17). 8254–8269. 28 indexed citations

12.

Yu, Wenqi, Ruyi Lin, Xueqin He, et al.. (2021). Self-propelled nanomotor reconstructs tumor microenvironment through synergistic hypoxia alleviation and glycolysis inhibition for promoted anti-metastasis. Acta Pharmaceutica Sinica B. 11(9). 2924–2936. 74 indexed citations

13.

Lin, Ruyi, Wenqi Yu, Xianchun Chen, & Huile Gao. (2021). Drug Delivery: Self‐Propelled Micro/Nanomotors for Tumor Targeting Delivery and Therapy (Adv. Healthcare Mater. 1/2021). Advanced Healthcare Materials. 10(1). 3 indexed citations

14.

Lin, Ruyi, Wenqi Yu, Xianchun Chen, & Huile Gao. (2020). Self‐Propelled Micro/Nanomotors for Tumor Targeting Delivery and Therapy. Advanced Healthcare Materials. 10(1). e2001212–e2001212. 91 indexed citations

15.

Shi, Yulin, Yajie Li, Jing Han, et al.. (2018). The prevalence of and factors associated with willingness to utilize HTC service among college students in China. BMC Public Health. 18(1). 1050–1050. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact